A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells. - Wikidata - wikimedia - TriplyDB

A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.

A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.

http://www.wikidata.org/entity/Q35023915

about

Harnessing the apoptotic programs in cancer stem-like cells Oncolytic virotherapy using herpes simplex virus: how far have we come?Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma.Current status of gene therapy for brain tumors.Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.Designing Herpes Viruses as Oncolytics.The art of gene therapy for glioma: a review of the challenging road to the bedside EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors.Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs Targeting cancer stem cells with oncolytic virus Glioma virus therapies between bench and bedside.Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.Oncolytic viral therapy: targeting cancer stem cells Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma.Oncolytic virotherapy for urological cancers.Oncolytic Immunotherapy for Treatment of Cancer.Oncolytic virus as a cancer stem cell killer: progress and challenges.Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.Immune and viral therapies for malignant primary brain tumors.Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.Oncolytic measles virus strains have significant antitumor activity against glioma stem cells.Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.

P2860

Q26801037-20C2C023-512A-49BF-A695-8DB9A7F64B57 Q26862461-F8137352-A4E6-40C4-8909-51FFBB3FBE30 Q26865911-232D6BBC-D9FC-4023-87BF-9C126E83DB2B Q26998111-C5FDA38A-B16B-4D19-A980-0A30D92177DD Q33579396-EE6A700D-3444-4F8B-835D-485913EFE309 Q34318157-BF1FFE4C-404F-45E1-86A4-ABBC1045F9F4 Q34715771-3E48005F-A224-4B99-985D-3E23C704D868 Q35545752-699B194F-B56D-4D22-B067-0AE33D7ABE02 Q35648484-9EB107A3-64AD-481E-B153-9CC6F7721230 Q35657822-F7664468-7499-4DA7-97C0-B52E7CE6F355 Q35867997-AAD36DC5-E16C-42AE-B547-91BAD229EDD8 Q36142487-A085F4C1-B4C6-4C9C-B6BF-E987C1A5D35B Q36527593-89D4CFA2-BC9D-46C0-8F8A-D6318AE3A12F Q36549443-041665A4-F339-45DE-A5AF-E7B54E5A5F27 Q36644898-1BCCF98A-B98F-42C5-AD96-C1AB5B68624B Q36849213-EBDF6126-C4FA-43EF-A4A7-33ED9FB47C85 Q36861550-CB157E48-A146-4E6A-B795-E0DC23BEDB14 Q37031896-DD3D6E64-5A66-4793-AF95-A299FB54FB71 Q37044088-4283C3B6-A6CE-49EF-9D78-317016F85505 Q37580510-DA7F2EBE-8E66-499C-95B1-CB5342BBCCB6 Q37899230-0B94993B-39CC-4EA4-9CC5-3DCC05698685 Q38025696-52AB11E1-0EA5-4E25-9E85-F052809713B0 Q38119845-88188B84-DDE6-4642-8239-A0B855E187CF Q38212255-CCB621F4-1547-49A7-B330-406C0B5AF0A1 Q38237657-1355665C-B5A4-4DEB-A2D4-44F3183FF63E Q38400073-026F4FB7-CCD0-4F17-B23E-E9C00D83D388 Q38615069-D3BAC21D-C95A-4E86-B259-793345F4E628 Q38842126-90A0C901-67C3-4F0D-B426-49755A11F648 Q38848223-E800DD84-4811-4C9D-9185-589095545931 Q38881477-59F726D2-C2D5-4282-BB4F-D5EB4E519AB2 Q39020795-5A6F5C7D-B1BF-4AE5-A2E8-26D5C983FA60 Q39168899-37E4E462-0211-4004-B509-3E3E304F535E Q39380065-C5B7C88C-8779-46D9-BBA7-25772402218A Q39462647-9E42F315-7A4A-4D25-A588-D77E52796BF2 Q40258666-63BC2035-F0EE-4893-A20A-8E86523A47CD Q40509393-86A5F2D7-5C95-4AB2-8381-03D23F611CB1 Q40867510-8F807458-A11C-4F44-9728-4B6C0D1C848F Q41869447-76F68264-0892-4346-9D35-C2327ADDAA8B Q42205615-8F37E8E4-5B59-4AC6-A662-A6B650695993 Q52337612-6EEE0DE1-34D9-4B07-8E19-685D2C30E9C1

P2860

A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.

http://www.wikidata.org/entity/Q35023915

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A novel oncolytic herpes simpl ...... arget glioblastoma stem cells.

@ast

A novel oncolytic herpes simpl ...... arget glioblastoma stem cells.

@en

type

label

A novel oncolytic herpes simpl ...... arget glioblastoma stem cells.

@ast

A novel oncolytic herpes simpl ...... arget glioblastoma stem cells.

@en

prefLabel

A novel oncolytic herpes simpl ...... arget glioblastoma stem cells.

@ast

A novel oncolytic herpes simpl ...... arget glioblastoma stem cells.

@en

P1433

Q35023915-6324B955-85B3-409A-833E-5DD63B1BF4FA

P1476

Q35023915-9E3F021B-01DD-403A-A53F-056D80DD2893

P2093

Q35023915-43A0811D-5325-45F2-BE46-41463A31C215

Q35023915-834D14BC-227B-41AF-9B09-C8810BCCE1D2

P2860

Q35023915-03B938D8-FA78-45D0-9F38-AF09C2C9B0D9

Q35023915-04E0E50F-53B9-4410-9F6B-670D2338938A

Q35023915-06B15051-684C-492F-A1D1-EF5C21113C61

Q35023915-0AF7D905-1CFF-484A-B636-24EB7BA8F58C

Q35023915-11FDE72A-B738-4D90-8576-F967A932E133

Q35023915-137FE61E-F3AB-4755-AD96-C175736332F9

Q35023915-1844422F-D64A-479F-9608-F736093CFAA4

Q35023915-2B4953CD-D676-48F8-AED6-3D3165742E3A

Q35023915-391CAD08-5A15-43BE-88C7-A81C9E7B6C1F

Q35023915-39F129AC-EC7D-4BCE-981D-61F5FB547A55

P304

Q35023915-A83D0060-7E15-4050-BBB3-2CC3F20FC07A

P31

Q35023915-2B5CCA34-D263-4F6D-BE1E-8044D33E8E94

P356

Q35023915-B9EB8D91-7B13-45F9-803F-84170E643158

P407

Q35023915-7FE13B8E-B63D-4989-BEB5-49B33C0831D0

P433

Q35023915-C8D42917-ABF7-4DC8-9F0C-4F897BCC63DD

P478

Q35023915-89C3A940-46D4-4C0B-AA01-01E6C00D76EF

P50

Q35023915-A627AA63-8D43-45E5-9242-0A8B8F4144FA

Q35023915-D6E1E74A-D0C4-47A0-A1FC-00F639F7A7FC

P577

Q35023915-A87378D5-CA26-4C92-83AC-D10F8ACA7B1C

P698

Q35023915-BB758ECB-ACE5-4BC8-8EA9-B084F9DFF988

P921

Q35023915-D20453A5-CE75-4629-A340-51640694A83A

P932

Q35023915-26662CCF-3792-4E32-9189-8E72CE47901E

P356

1078-0432.CCR-10-3142

P1433

Clinical Cancer Research

P1476

A novel oncolytic herpes simpl ...... target glioblastoma stem cells

@en

P2093

Hiroaki Wakimoto

http://www.w3.org/2001/XMLSchema#string

Ryuichi Kanai

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors

The PI3K pathway as drug target in human cancer

An integrated genomic analysis of human glioblastoma multiforme

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Herpes simplex virus 1 protein kinase is encoded by open reading frame US3 which is not essential for virus growth in cell culture

Oncolytic herpes simplex virus vectors for cancer virotherapy

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Malignant gliomas in adults

P304

3686-3696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-3142

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Samuel D Rabkin

Robert L Martuza

P577

2011-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21505062

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3107877

http://www.w3.org/2001/XMLSchema#string